{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:52:42Z","timestamp":1793220762771,"version":"4.5.0"},"reference-count":22,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Shanghai Sixth People's Hospital Affiliated to Jiao Tong University School of Medicine Hospital-level project Fund","award":["ynhg202317"],"award-info":[{"award-number":["ynhg202317"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Appl Thromb Hemost"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the relationship between the transient increase in D-dimer following anticoagulant therapy and thrombolysis at 30 days in patients with pulmonary embolism (PE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Patients diagnosed with PE at our hospital were included in the study. CT pulmonary angiography (CTPA) was performed 7-10 days after starting anticoagulant therapy. Patients were divided into two groups: the change group and the non-change group, based on whether the thrombus had broken into smaller clots and\/or dissolved compared to baseline. Plasma D-dimer levels were measured 1-10 days after anticoagulant therapy to observe any transient increase. The correlation between the transient D-dimer increase and thrombolysis at 30 days in PE patients was analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 172 patients with PE were included. The rate of thrombus change was 63.4% (75\/172) at 7-10 days after anticoagulant therapy. The proportion of thrombolysis at 30 days was 68.6% (118\/172). Spearman correlation analysis showed a significant correlation between the transient increase in D-dimer and thrombus changes (Rs\u2009=\u20090.482,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001), between thrombus changes and thrombolysis at 30 days (Rs\u2009=\u20090.413,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001), and between the transient increase in D-dimer and thrombolysis at 30 days (Rs\u2009=\u20090.540,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001). ROC curve analysis indicated that the transient increase in D-dimer predicted thrombus changes (AUC: 0.750, 95%CI: 0.673-0.827,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001), and predicted thrombolysis at 30 days (AUC: 0.786, 95%CI: 0.714-0.858,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001). Thrombus changes also predicted thrombolysis at 30 days (AUC: 0.712, 95%CI: 0.626-0.797,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>After anticoagulant therapy for PE, D-dimer levels may transiently increase. The rate of thrombolysis at 30 days was higher, and a transient increase in D-dimer indicated a higher likelihood of thrombolysis at 30 days.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10760296251335250","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:47:03Z","timestamp":1744714023000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Correlation Between the Transient Increase of D-Dimer and Thrombolysis at 30d after Anticoagulation Therapy in Patients with Pulmonary Embolism"],"prefix":"10.1177","volume":"31","author":[{"given":"Yang","family":"Danrong","sequence":"first","affiliation":[{"name":"Shanghai Sixth People's Hospital Affiliated to Jiao Tong University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Yan","sequence":"additional","affiliation":[{"name":"Chongqing General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-6079","authenticated-orcid":false,"given":"Liu","family":"Yi","sequence":"additional","affiliation":[{"name":"Shanghai Sixth People's Hospital Affiliated to Jiao Tong University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.8594"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-023-00559-3"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12113629"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjacc\/zuab089"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S289289"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEJ.0000000000000722"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020943378"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.20750"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.12.015"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13728"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123441"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-022-00368-0"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.02.033"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94346-7"},{"key":"e_1_3_4_16_2","first-page":"1060","article-title":"Pulmonary embolism and pulmonary vascular diseases group of Chinese thoracic society, pulmonary embolism and pulmonary vascular disease working committee of Chinese association of chest physicians, national cooperation group on prevention and treatment of pulmonary embolism and pulmonary vascular disease. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism","volume":"98","year":"2018","unstructured":"Pulmonary embolism and pulmonary vascular diseases group of Chinese thoracic society, pulmonary embolism and pulmonary vascular disease working committee of Chinese association of chest physicians, national cooperation group on prevention and treatment of pulmonary embolism and pulmonary vascular disease. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism. Zhonghua Yi Xue Za Zhi. 2018;98(14):1060-1087.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2303030083"},{"issue":"9","key":"e_1_3_4_18_2","article-title":"Efficacy and safety of rivaroxaban versus warfarin for the treatment of acute pulmonary embolism: a real-world study","volume":"16","author":"Huang Y","year":"2020","unstructured":"Huang Y, Duan L, He W, et al. Efficacy and safety of rivaroxaban versus warfarin for the treatment of acute pulmonary embolism: a real-world study. Circ Cardiovasc Interv. 2020;16(9): e013242. doi: https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.123.013242","journal-title":"Circ Cardiovasc Interv"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2018.01.041"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2023.12.045"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.67.02.20200539"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2018.01.048"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-019-1219-8"}],"container-title":["Clinical and Applied Thrombosis\/Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251335250","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10760296251335250","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251335250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:05:10Z","timestamp":1777385110000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10760296251335250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":22,"alternative-id":["10.1177\/10760296251335250"],"URL":"https:\/\/doi.org\/10.1177\/10760296251335250","relation":{},"ISSN":["1076-0296","1938-2723"],"issn-type":[{"value":"1076-0296","type":"print"},{"value":"1938-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"article-number":"10760296251335250"}}